Valuation: Orion Infusion Limited

Market Cap 6.37B 51.58M 45.31M 42.13M 38.66M 72.64M 4.97B 73.76M 500M 195M 2.44B 194M 189M 8.44B P/E 2024
231x
P/E 2025 182x
Enterprise Value 6.67B 54.03M 47.45M 44.13M 40.5M 76.09M 5.2B 77.26M 524M 205M 2.56B 203M 198M 8.84B EV / Sales 2024
12.2x
EV / Sales 2025 10.1x
Free-Float
59.39%
Yield 2024
0.25%
Yield 2025 0.64%
1 day-0.48%
1 week-4.62%
Current month-7.70%
1 month-6.54%
3 months-10.14%
6 months-20.08%
Current year-15.45%
1 week 286.8
Extreme 286.8
299
1 month 285
Extreme 285
314.8
Current year 285
Extreme 285
391.8
1 year 285
Extreme 285
587.5
3 years 217.2
Extreme 217.2
726.9
5 years 69.5
Extreme 69.5
1,000
10 years 44
Extreme 44
1,000
Manager TitleAgeSince
Chief Executive Officer 45 2013-12-31
Director of Finance/CFO - 2020-11-07
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 71 2013-12-31
Director/Board Member 71 1983-05-04
Director/Board Member 45 1999-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.48%-4.62%-14.35%-22.86% 47.61M
+0.86%+1.43%+47.17%+161.40% 1,067B
+1.59%+4.09%+56.51%+52.79% 635B
+0.95%+1.91%+36.30%+83.13% 458B
+1.60%+6.25%+37.00%+30.00% 347B
-0.60%+1.52%+36.67%+39.80% 295B
-0.14%+0.60%+17.29%+18.19% 262B
+0.09%-2.82%-29.09%-41.29% 216B
+1.22%+2.66%+22.66%+59.81% 203B
-1.18%-3.70%+11.28%+67.43% 161B
Average +0.39%+0.96%+22.14%+44.84% 364.36B
Weighted average by Cap. +0.76%+1.95%+35.99%+78.15%

Financials

2024 2025
Net sales 827M 6.7M 5.88M 5.47M 5.02M 9.43M 645M 9.58M 64.96M 25.38M 317M 25.14M 24.6M 1.1B 665M 5.38M 4.73M 4.4M 4.03M 7.58M 518M 7.7M 52.2M 20.4M 255M 20.2M 19.77M 881M
Net income 42.33M 343K 301K 280K 257K 483K 33M 490K 3.32M 1.3M 16.22M 1.29M 1.26M 56.09M 35.02M 284K 249K 232K 212K 399K 27.3M 405K 2.75M 1.07M 13.42M 1.06M 1.04M 46.41M
Net Debt 290M 2.35M 2.07M 1.92M 1.76M 3.31M 226M 3.36M 22.81M 8.91M 111M 8.83M 8.64M 385M 302M 2.45M 2.15M 2M 1.83M 3.44M 236M 3.5M 23.72M 9.27M 116M 9.18M 8.98M 400M
Logo Orion Infusion Limited
Orion Infusion Limited is a Bangladesh-based large volume parenteral (LVP) manufacturing company. The Company is a provider of medicines and healthcare services through approximately 28 brands and 42 presentations of various formulations. It is engaged in the manufacturing and marketing of intravenous (I.V.) fluid, lifesaving intravenous medicine and intravascular saline, which include fluid and nutrient, fluid and electrolyte, fat emulsion for I.V. use, fluid, nutrient and electrolyte, plasma substitute, antiulcerant, osmotic diuretic and amino acid solutions. The Company has the manufacturing facilities to produce I.V. Rehydration Solutions, Electrolyte Solutions, and Solution for Acidosis, Ranitidine I.V. infusion, Anti-Microbial products, namely, Ciprofloxacin I.V., Metronidazole I.V., and others. Its production plant is situated in Maikuli, P.S. Rupganj, and District- Naraynganj, Bangladesh.
Employees
563
Date Price Change Volume
26-07-23 BDT 288.90 -0.48% 132,491
26-07-22 BDT 290.30 -1.06% 177,409
26-07-21 BDT 293.40 +0.17% 185,294
26-07-20 BDT 292.90 -0.98% 173,596
26-07-19 BDT 295.80 -2.34% 179,031
  1. Stock Market
  2. Stocks
  3. ORIONINFU Stock